Role of estrogen receptor-related antigen in initiating the growth of human glioma cells

Journal of Neurosurgery

Volumn 100, Issue 5, 2004, Pages 923-930

  Khalid, M Humayun ^a   Shibata, Shobu ^b   Furukawa, Koichi ^b   Nadel, Amal ^b   Ammerman, Matthew D ^b   Caputy, Anthony J ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Antibody treatment; Cell culture growth; Estrogen receptor related antigen; Glioma; Growth inhibition

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR RELATED ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL TYPE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TUMOR CELL LINE; WESTERN BLOTTING;

EID: 2042485546     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2004.100.5.0923     Document Type: Article

References (23)

1. Cano A, Coffer AI, Adatia R, et al: Histochemical studies with an estrogen receptor-related protein in human breast tumors. Cancer Res 46:6475-6480, 1986
2. Ciocca DR, Luque EH: Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res Treat 20:33-42, 1991
3. Coffer AI, King RJB: Characterization of p29, an estrogen-receptor associated tumor marker. J Steroid Biochem 31:745-750, 1988
4. Coffer AI, Lewis KM, Brockas AJ, et al: Monoclonal antibodies against a component related to soluble estrogen receptor. Cancer Res 45:3686-3693, 1985
5. Coffer AI, Spiller GH, Lewis KM, et al: Immunoradiometric studies with monoclonal antibody against a component related to human estrogen receptor. Cancer Res 45:3694-3698, 1985
6. Ergun S, Ungefroren H, Holstein AF, et al: Estrogen and progesterone receptors and estrogen receptor-related antigen (ER-D5) in human epididymis. Mol Reprod Dev 47:448-455, 1997
7. Fan Z, Masui H, Altas I, et al: Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 53:4322-4328, 1993
8. Giri DD, Dangerfield VJM, Lonsdale R, et al: Immunohistology of oestrogen receptor and D5 antigen in breast cancer; correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay. J Clin Pathol 40:734-740, 1987
9. Harrison JD, Jones JA, Ellis IO, et al: Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br J Surg 78:334-336, 1991
10. Harrison JD, Morris DL, Ellis IO, et al: The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 64:1007-1010, 1989
11. Hayward JR, Coffer AI, King RJB: Immunoaffinity purification and characterization of p29 - an estrogen receptor related protein. J Steroid Biochem Mol Biol 37:513-519, 1990
12. Horimi T, Morita S, Takeda I, et al: [Hormone therapy of tamoxifen in resected carcinoma of the pancreas.] Nippon Geka Gakkai Zasshi 94:730-735, 1993 (Jpn)
13. Kanitakis J, Zambruno G, Viac J, et al: Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol 16:272-276, 1989
14. Khalid H: Immunohistochemical study of estrogen receptor-related antigen, progesterone, and estrogen receptors in human intracranial meningiomas. Cancer 74:679-685, 1994
15. Khalid H, Yasunaga A, Kishikawa M, et al: Immunohistochemical expression of the estrogen receptor related antigen (ER-D5) in the human intracranial tumors. Cancer 75:2571-2578, 1995
16. King RJB, Coffer AI: The generation of antibodies against partially purified estradiol receptor from human myometrium, in Jordan VC (ed): Estrogen/Antiestrogen Action in Breast Cancer Therapy. Madison: University of Wisconsin Press, 1986, pp 375-394
17. King RJB, Finley JR, Coffer AI, et al: Characterization and biological relevance of a 29-kDa, oestrogen receptor-ralated protein. J Steroid Biochem 27:471-475, 1987
18. Leimola-Virtanen R, Salo T, Toikkanen S, et al: Expression of estrogen receptor (ER) in oral mucosa and salivary glands. Maturitas 36:131-137, 2000
19. Maiorano E, Botticella MA, Marzullo A, et al: Expression of ER-D5 and EGFr in laryngeal carcinoma and pre-malignant epithelium. Acta Otolaryngol Suppl 527:95-99, 1997
20. Mendelsohn ME, Zhu Y, O'Neill S: The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein. Proc Natl Acad Sci USA 88:11212-11216, 1991
21. Mohanam S, Sawaya R, McCutcheon I, et al: Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53:4143-4147, 1993
22. Takeda H, Yamakawa M, Takahashi T, et al: An immunohistochemical study with an estrogen receptor-related protein (ER-D5) in human colorectal cancer. Cancer 69:907-912, 1992
23. Viac J, Su H, Reano A, et al: Distribution of an estrogen receptor-related protein (P29) in normal skin and in cultured human keratinocytes. J Dermatol 16:98-102, 1989